<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 750px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 750px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "label": "A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MRNA", "label": "MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MICRORNAS", "label": "MICRORNAS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "label": "AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::AHRR MRNA", "label": "AHRR MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PPP1R3C MRNA", "label": "PPP1R3C MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ALDH1A1", "label": "ALDH1A1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CD44", "label": "CD44", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ABCG2", "label": "ABCG2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::NANOG", "label": "NANOG", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GALNT10 MRNA", "label": "GALNT10 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::nan", "label": "nan", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TBX5-AS1", "label": "TBX5-AS1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "label": "RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7D-5P", "label": "LET-7D-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-203A", "label": "MIR-203A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-200B", "label": "MIR-200B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-200C", "label": "MIR-200C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-191", "label": "MIR-191", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "label": "Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CIRCCELSR1", "label": "CIRCCELSR1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CD44 MRNA", "label": "CD44 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::FOXM1 MRNA", "label": "FOXM1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::COL11A1 MRNA", "label": "COL11A1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIRNA-137", "label": "MIRNA-137", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "label": "Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-21", "label": "MIR-21", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-141", "label": "MIR-141", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-200A", "label": "MIR-200A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-203", "label": "MIR-203", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-205", "label": "MIR-205", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-214", "label": "MIR-214", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30-5P", "label": "MIR-30-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-622", "label": "MIR-622", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "label": "Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-200 FAMILY", "label": "MIR-200 FAMILY", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30 FAMILY", "label": "MIR-30 FAMILY", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-429", "label": "MIR-429", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1273G-3P", "label": "MIR-1273G-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-222", "label": "MIR-222", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-145", "label": "MIR-145", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "label": "Role of different non-coding RNAs as ovarian Cancer biomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-130A", "label": "MIR-130A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-29B", "label": "MIR-29B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-125B", "label": "MIR-125B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-29A", "label": "MIR-29A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7", "label": "LET-7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-199A", "label": "MIR-199A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-140", "label": "MIR-140", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-125B1", "label": "MIR-125B1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-29C", "label": "MIR-29C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-101", "label": "MIR-101", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-718", "label": "MIR-718", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-106A", "label": "MIR-106A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-155", "label": "MIR-155", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-494", "label": "MIR-494", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PIR-219", "label": "PIR-219", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PIR-234", "label": "PIR-234", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PIR-256", "label": "PIR-256", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PIR-52207", "label": "PIR-52207", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PIR-33733", "label": "PIR-33733", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TRF-03357", "label": "TRF-03357", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TRF-5GLU", "label": "TRF-5GLU", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TS-101", "label": "TS-101", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TS-46", "label": "TS-46", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TRF-1", "label": "TRF-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TRF-3", "label": "TRF-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TRF-5", "label": "TRF-5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TRF-2", "label": "TRF-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::50TIRNA", "label": "50TIRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::30TIRNA", "label": "30TIRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::I-TRFS", "label": "I-TRFS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::H19", "label": "H19", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HOTAIR", "label": "HOTAIR", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::XIST", "label": "XIST", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::UCA1", "label": "UCA1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MALAT1", "label": "MALAT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PVT1", "label": "PVT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GAS5", "label": "GAS5", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HOXD-AS1", "label": "HOXD-AS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SPRY4-IT1", "label": "SPRY4-IT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PCAT-1", "label": "PCAT-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CIRCRNA", "label": "CIRCRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SNORNA", "label": "SNORNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "label": "Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::NEAT1", "label": "NEAT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ANRIL", "label": "ANRIL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CCAT1", "label": "CCAT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CCAT2", "label": "CCAT2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CRNDE", "label": "CRNDE", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::AB073614", "label": "AB073614", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TC0100223", "label": "TC0100223", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TC0101686", "label": "TC0101686", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TC0101441", "label": "TC0101441", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LOC645249", "label": "LOC645249", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LOC100128881", "label": "LOC100128881", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LOC100292680", "label": "LOC100292680", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LOC100190986", "label": "LOC100190986", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ASAP1-IT1", "label": "ASAP1-IT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::FAM215A", "label": "FAM215A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LINC00472", "label": "LINC00472", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HOXA10-AS", "label": "HOXA10-AS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HOXA11-AS", "label": "HOXA11-AS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HOTTIP", "label": "HOTTIP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LUCAT1", "label": "LUCAT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LINC00961", "label": "LINC00961", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LINC00515", "label": "LINC00515", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LINC-TNFRSF19-1", "label": "LINC-TNFRSF19-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LINC-CARS2-2", "label": "LINC-CARS2-2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TUG1", "label": "TUG1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::OVAAL", "label": "OVAAL", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::NRCP", "label": "NRCP", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MEG3", "label": "MEG3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HOST2", "label": "HOST2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RP11-284N8.3.1", "label": "RP11-284N8.3.1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::AC104699.1.1", "label": "AC104699.1.1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RUNX1-IT1", "label": "RUNX1-IT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::FAL1", "label": "FAL1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "label": "Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30A-5P", "label": "MIR-30A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-106A-5P", "label": "MIR-106A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-93-5P", "label": "MIR-93-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-122-5P", "label": "MIR-122-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-185-5P", "label": "MIR-185-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-99B-5P", "label": "MIR-99B-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-144-3P", "label": "MIR-144-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-337-3P", "label": "MIR-337-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-373", "label": "MIR-373", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-133B", "label": "MIR-133B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-148A", "label": "MIR-148A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-200A-3P", "label": "MIR-200A-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-509-3-5P", "label": "MIR-509-3-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-509-5P", "label": "MIR-509-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-433", "label": "MIR-433", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-630", "label": "MIR-630", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-802", "label": "MIR-802", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1271", "label": "MIR-1271", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-193-5P", "label": "MIR-193-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-19A-3P", "label": "MIR-19A-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-21-5P", "label": "MIR-21-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-21-3P", "label": "MIR-21-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-26A", "label": "MIR-26A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-26B", "label": "MIR-26B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-19B-3P", "label": "MIR-19B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-106B-5P", "label": "MIR-106B-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-146A", "label": "MIR-146A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-146B", "label": "MIR-146B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-150-5P", "label": "MIR-150-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-191-5P", "label": "MIR-191-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-206", "label": "MIR-206", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-34C-5P", "label": "MIR-34C-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-645", "label": "MIR-645", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-193A-5P", "label": "MIR-193A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-125A-3P", "label": "MIR-125A-3P", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "label": "Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::EPCAM", "label": "EPCAM", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HER2", "label": "HER2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MUC1", "label": "MUC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::WT1", "label": "WT1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::P16", "label": "P16", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PAX8", "label": "PAX8", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ACTIN", "label": "ACTIN", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "label": "SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SLC11A2 MRNA", "label": "SLC11A2 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "label": "SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SPON1 MRNA", "label": "SPON1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SPON1 TRANSCRIPTS", "label": "SPON1 TRANSCRIPTS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "label": "SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SUGT1 MRNA", "label": "SUGT1 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "label": "Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MICRORNA-204", "label": "MICRORNA-204", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNU6-2", "label": "RNU6-2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "label": "Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SIRNA", "label": "SIRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "label": "Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CFL1 MRNA", "label": "CFL1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CYPA MRNA", "label": "CYPA MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PFN1 MRNA", "label": "PFN1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::EZR MRNA", "label": "EZR MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "label": "Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "label": "Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-199A2", "label": "MIR-199A2", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::214", "label": "214", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7 FAMILY", "label": "LET-7 FAMILY", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "label": "The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-200", "label": "MIR-200", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "label": "The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIRNAS", "label": "MIRNAS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "label": "The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-222-3P", "label": "MIR-222-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-940", "label": "MIR-940", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-125B-5P", "label": "MIR-125B-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-181D-5P", "label": "MIR-181D-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-223", "label": "MIR-223", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "label": "The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-205-5P", "label": "MIR-205-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-145-5P", "label": "MIR-145-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-10A-5P", "label": "MIR-10A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-346", "label": "MIR-346", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-328-3P", "label": "MIR-328-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-508-3P", "label": "MIR-508-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1294", "label": "MIR-1294", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-16", "label": "MIR-16", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CEL-MIR-39", "label": "CEL-MIR-39", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNU6B (U6)", "label": "RNU6B (U6)", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::UNISP6", "label": "UNISP6", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-100", "label": "MIR-100", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-99", "label": "MIR-99", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-57", "label": "MIR-57", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-51", "label": "MIR-51", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-10", "label": "MIR-10", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "label": "The biological significance and clinical applications of exosomes in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-210", "label": "MIR-210", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "label": "The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CXCL9 MRNA", "label": "CXCL9 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CXCL11 MRNA", "label": "CXCL11 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CXCL13 MRNA", "label": "CXCL13 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::STAT1 MRNA", "label": "STAT1 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "label": "The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LGALS8 MRNA ISOFORMS", "label": "LGALS8 MRNA ISOFORMS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-424-3P", "label": "MIR-424-3P", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "label": "The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HSA-MIR-1273G-3P", "label": "HSA-MIR-1273G-3P", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "label": "Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MSN MRNA", "label": "MSN MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::KRT19 MRNA", "label": "KRT19 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::COL5A2 MRNA", "label": "COL5A2 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::COL1A2 MRNA", "label": "COL1A2 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::BMP5 MRNA", "label": "BMP5 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::F10 MRNA", "label": "F10 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::KRT7 MRNA", "label": "KRT7 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::JUNB MRNA", "label": "JUNB MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::BMP4 MRNA", "label": "BMP4 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MMP1 MRNA", "label": "MMP1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::KLK4 MRNA", "label": "KLK4 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::KLK5 MRNA", "label": "KLK5 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::KLK6 MRNA", "label": "KLK6 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::KLK7 MRNA", "label": "KLK7 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "label": "ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ZNF76 MRNA", "label": "ZNF76 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TRNASEC", "label": "TRNASEC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PRE-MRNA", "label": "PRE-MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "label": "Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-320", "label": "MIR-320", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-126", "label": "MIR-126", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-93", "label": "MIR-93", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "label": "Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "label": "Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GALECTIN-1 MRNA", "label": "GALECTIN-1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GALECTIN-3 MRNA", "label": "GALECTIN-3 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GALECTIN-4 MRNA", "label": "GALECTIN-4 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GALECTIN-8 MRNA", "label": "GALECTIN-8 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GALECTIN-9 MRNA", "label": "GALECTIN-9 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GAPDH MRNA", "label": "GAPDH MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TOTAL RNA", "label": "TOTAL RNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "label": "Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ACAT1 MRNA", "label": "ACAT1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::KI67 MRNA", "label": "KI67 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::18S RRNA", "label": "18S RRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "label": "BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::BAIAP2L1 MRNA", "label": "BAIAP2L1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::FGFR3-BAIAP2L1 TRANSCRIPTS", "label": "FGFR3-BAIAP2L1 TRANSCRIPTS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "label": "Microvesicles as Potential Ovarian Cancer Biomarkers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::NCRNA", "label": "NCRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7A", "label": "LET-7A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7B", "label": "LET-7B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7C", "label": "LET-7C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7D", "label": "LET-7D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7E", "label": "LET-7E", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7F", "label": "LET-7F", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-10A", "label": "MIR-10A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-10B", "label": "MIR-10B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-20A", "label": "MIR-20A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-23A", "label": "MIR-23A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-23B", "label": "MIR-23B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-27A", "label": "MIR-27A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-92", "label": "MIR-92", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-99A", "label": "MIR-99A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-103", "label": "MIR-103", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-106B", "label": "MIR-106B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-122", "label": "MIR-122", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-125A", "label": "MIR-125A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-127", "label": "MIR-127", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-134", "label": "MIR-134", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-143", "label": "MIR-143", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-182", "label": "MIR-182", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-221", "label": "MIR-221", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-296", "label": "MIR-296", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-302D", "label": "MIR-302D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-335", "label": "MIR-335", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-410", "label": "MIR-410", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-422A", "label": "MIR-422A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-424", "label": "MIR-424", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-432", "label": "MIR-432", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-508", "label": "MIR-508", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-519A", "label": "MIR-519A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-648", "label": "MIR-648", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-662", "label": "MIR-662", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-663", "label": "MIR-663", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "label": "Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-29", "label": "MIR-29", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-23", "label": "MIR-23", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-31", "label": "MIR-31", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-217", "label": "MIR-217", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-484", "label": "MIR-484", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-617", "label": "MIR-617", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-128", "label": "MIR-128", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "label": "Biomarkers and Strategies for Early Detection of Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MICRO-RNAS", "label": "MICRO-RNAS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "label": "Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-99B", "label": "MIR-99B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-15", "label": "MIR-15", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-148B", "label": "MIR-148B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-449A", "label": "MIR-449A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-449B", "label": "MIR-449B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-34B", "label": "MIR-34B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-34C", "label": "MIR-34C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-140-3P", "label": "MIR-140-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-139-5P", "label": "MIR-139-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-133A", "label": "MIR-133A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-22", "label": "MIR-22", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-183", "label": "MIR-183", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-17-92", "label": "MIR-17-92", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "label": "CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CD24 MRNA", "label": "CD24 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SNAIL MRNA", "label": "SNAIL MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::E-CADHERIN MRNA", "label": "E-CADHERIN MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::\u0392-ACTIN MRNA", "label": "\u0392-ACTIN MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "label": "CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CX3CR1 MRNA", "label": "CX3CR1 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "label": "A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-7", "label": "MIR-7", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-320A", "label": "MIR-320A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-6126", "label": "MIR-6126", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "label": "CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CXCR4 MRNA", "label": "CXCR4 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::NM_003467", "label": "NM_003467", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CXCR4 SHRNA", "label": "CXCR4 SHRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "label": "Biomarkers in ovarian cancer: To be or not to be", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNA SIGNATURE", "label": "RNA SIGNATURE", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "label": "Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR124-2", "label": "MIR124-2", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "label": "Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LNCRNA", "label": "LNCRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TRNA", "label": "TRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIRNA", "label": "MIRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-200C-3P", "label": "MIR-200C-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-376A", "label": "MIR-376A", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "label": "Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MICRORNA-30A-5P", "label": "MICRORNA-30A-5P", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "label": "Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LINC01010", "label": "LINC01010", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LBX2-AS1", "label": "LBX2-AS1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HSA-MIR-146A-5P", "label": "HSA-MIR-146A-5P", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "label": "Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::DSG2 MRNA", "label": "DSG2 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "label": "Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "label": "Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ALG5 MRNA", "label": "ALG5 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::GPR107 MRNA", "label": "GPR107 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::NUP188 MRNA", "label": "NUP188 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "label": "Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TSRNA", "label": "TSRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "label": "Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-15A", "label": "MIR-15A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-15B", "label": "MIR-15B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-19B", "label": "MIR-19B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-154", "label": "MIR-154", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-154*", "label": "MIR-154*", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-377", "label": "MIR-377", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-368", "label": "MIR-368", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-299", "label": "MIR-299", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30A", "label": "MIR-30A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30C1", "label": "MIR-30C1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30C-1", "label": "MIR-30C-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-132", "label": "MIR-132", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30B", "label": "MIR-30B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-192", "label": "MIR-192", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-194", "label": "MIR-194", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-32", "label": "MIR-32", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-18A", "label": "MIR-18A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-25", "label": "MIR-25", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-142-3P", "label": "MIR-142-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30D", "label": "MIR-30D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30E", "label": "MIR-30E", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1274A", "label": "MIR-1274A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-625-3P", "label": "MIR-625-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-720", "label": "MIR-720", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-17", "label": "MIR-17", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-150", "label": "MIR-150", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-92A", "label": "MIR-92A", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "label": "Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::NON-CODING RNAS", "label": "NON-CODING RNAS", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "label": "Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1290", "label": "MIR-1290", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-129B-1-3P", "label": "MIR-129B-1-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-3131", "label": "MIR-3131", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNU-6B", "label": "RNU-6B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNU-48", "label": "RNU-48", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "label": "Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-891-5P", "label": "MIR-891-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-98-5P", "label": "MIR-98-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-214-3P", "label": "MIR-214-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1307", "label": "MIR-1307", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-141-3P", "label": "MIR-141-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1270", "label": "MIR-1270", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-6780B-5P", "label": "MIR-6780B-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-212-3P", "label": "MIR-212-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-150-3P", "label": "MIR-150-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LHX6 MRNA", "label": "LHX6 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CIRCPUM1", "label": "CIRCPUM1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CIRCWHSC1", "label": "CIRCWHSC1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CIRCCDR1AS", "label": "CIRCCDR1AS", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CIRCFOXP1", "label": "CIRCFOXP1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "label": "Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HELQ MRNA", "label": "HELQ MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::SI-HELQ", "label": "SI-HELQ", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "label": "High BMP7 expression is associated with poor prognosis in ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::BMP7 MRNA", "label": "BMP7 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "label": "Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "label": "Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PKP1 MRNA", "label": "PKP1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PKP2 MRNA", "label": "PKP2 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PKP3 MRNA", "label": "PKP3 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "label": "Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30C", "label": "MIR-30C", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "label": "Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::EIF2B5 MRNA", "label": "EIF2B5 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::FAM64A MRNA", "label": "FAM64A MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-454-3P", "label": "MIR-454-3P", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "label": "MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-34A", "label": "MIR-34A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-376C", "label": "MIR-376C", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-30E-3P", "label": "MIR-30E-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-370", "label": "MIR-370", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7A-3", "label": "LET-7A-3", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-9", "label": "MIR-9", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-181D", "label": "MIR-181D", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-532-5P", "label": "MIR-532-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-642", "label": "MIR-642", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-199", "label": "MIR-199", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "label": "ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ADAM12 MRNA", "label": "ADAM12 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "label": "MicroRNAs as Potential Biomarkers in Gynecological Cancers", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-492", "label": "MIR-492", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-182-5P", "label": "MIR-182-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-182-3P", "label": "MIR-182-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-183-5P", "label": "MIR-183-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1271-5P", "label": "MIR-1271-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-15B-5P", "label": "MIR-15B-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-141-5P", "label": "MIR-141-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-135B-3P", "label": "MIR-135B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-130B-5P", "label": "MIR-130B-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-574-3P", "label": "MIR-574-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-99A-5P", "label": "MIR-99A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-210-3P", "label": "MIR-210-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-34A-5P", "label": "MIR-34A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-34B-3P", "label": "MIR-34B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-34C-3P", "label": "MIR-34C-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-29A-3P", "label": "MIR-29A-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-29C-5P", "label": "MIR-29C-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-199A-3P", "label": "MIR-199A-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-221-3P", "label": "MIR-221-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-10B-5P", "label": "MIR-10B-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-338", "label": "MIR-338", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-512-5P", "label": "MIR-512-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-345", "label": "MIR-345", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-196A", "label": "MIR-196A", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-151", "label": "MIR-151", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-142-5P", "label": "MIR-142-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-200B-3P", "label": "MIR-200B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-766-3P", "label": "MIR-766-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-130B-3P", "label": "MIR-130B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-26A-5P", "label": "MIR-26A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LET-7I", "label": "LET-7I", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-375", "label": "MIR-375", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-3147", "label": "MIR-3147", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-223-5P", "label": "MIR-223-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-342-3P", "label": "MIR-342-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-106B-3P", "label": "MIR-106B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-365A-3P", "label": "MIR-365A-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-22-5P", "label": "MIR-22-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-144-5P", "label": "MIR-144-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-151A-5P", "label": "MIR-151A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-519B-3P", "label": "MIR-519B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-125B-1-3P", "label": "MIR-125B-1-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-19B-1-5P", "label": "MIR-19B-1-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-26B-3P", "label": "MIR-26B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MIR-1254-1", "label": "MIR-1254-1", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNO-MIR-29C-5P", "label": "RNO-MIR-29C-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNO-MIR-10B", "label": "RNO-MIR-10B", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNO-MIR-31", "label": "RNO-MIR-31", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNO-MIR-140", "label": "RNO-MIR-140", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MMU-MIR-140", "label": "MMU-MIR-140", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::RNU44", "label": "RNU44", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HSA-MIR-1274-1", "label": "HSA-MIR-1274-1", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "label": "Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::CHI3L1 MRNA", "label": "CHI3L1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::G6PDH MRNA", "label": "G6PDH MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "label": "Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HE4 MRNA", "label": "HE4 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "label": "Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::ICAM1 MRNA", "label": "ICAM1 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "label": "PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD1 MRNA", "label": "PSMD1 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD2 MRNA", "label": "PSMD2 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD3 MRNA", "label": "PSMD3 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD4 MRNA", "label": "PSMD4 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD5 MRNA", "label": "PSMD5 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD6 MRNA", "label": "PSMD6 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD7 MRNA", "label": "PSMD7 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD8 MRNA", "label": "PSMD8 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD9 MRNA", "label": "PSMD9 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD10 MRNA", "label": "PSMD10 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD11 MRNA", "label": "PSMD11 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD12 MRNA", "label": "PSMD12 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD13 MRNA", "label": "PSMD13 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PSMD14 MRNA", "label": "PSMD14 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MICRORNA", "label": "MICRORNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "label": "Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PRKCG MRNA", "label": "PRKCG MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "label": "Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PRDX-3 MRNA", "label": "PRDX-3 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PRDX-5 MRNA", "label": "PRDX-5 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::PRDX-6 MRNA", "label": "PRDX-6 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "label": "Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HSA-MIR-21-5P", "label": "HSA-MIR-21-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HSA-MIR-34A-5P", "label": "HSA-MIR-34A-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HSA-MIR-200B-3P", "label": "HSA-MIR-200B-3P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HSA-MIR-205-5P", "label": "HSA-MIR-205-5P", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::MS2 PHAGE GENOMIC RNA", "label": "MS2 PHAGE GENOMIC RNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "label": "Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "label": "Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TGF-\u03921 MRNA", "label": "TGF-\u03921 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TGF-\u03922 MRNA", "label": "TGF-\u03922 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TGF-\u03923 MRNA", "label": "TGF-\u03923 MRNA", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::TGF-\u03924 MRNA", "label": "TGF-\u03924 MRNA", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "label": "Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "shape": "box"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::C17ORF91", "label": "C17ORF91", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::HULC", "label": "HULC", "shape": "ellipse"}, {"color": "lightgreen", "font": {"color": "black"}, "id": "RNA::LNCRNA-ATB", "label": "LNCRNA-ATB", "shape": "ellipse"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "label": "Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "shape": "box"}, {"color": "lightblue", "font": {"color": "black"}, "id": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "label": "Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "shape": "box"}]);
                  edges = new vis.DataSet([{"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "RNA::MRNA"}, {"from": "ARTICLE::A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come", "to": "RNA::MICRORNAS"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "RNA::AHRR MRNA"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "RNA::PPP1R3C MRNA"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "RNA::ALDH1A1"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "RNA::CD44"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "RNA::ABCG2"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "RNA::NANOG"}, {"from": "ARTICLE::AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer", "to": "RNA::GALNT10 MRNA"}, {"from": "ARTICLE::nan", "to": "RNA::TBX5-AS1"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "RNA::LET-7D-5P"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "RNA::MIR-203A"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer", "to": "RNA::MIR-191"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "RNA::CIRCCELSR1"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "RNA::CD44 MRNA"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "RNA::FOXM1 MRNA"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "RNA::COL11A1 MRNA"}, {"from": "ARTICLE::Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements", "to": "RNA::MIRNA-137"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-203"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-205"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-214"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-30-5P"}, {"from": "ARTICLE::Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer", "to": "RNA::MIR-622"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-200 FAMILY"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-30 FAMILY"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-205"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-203"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-429"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-1273G-3P"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-222"}, {"from": "ARTICLE::Role of biomarkers for early detection of ovarian cancer \r\nrecurrence", "to": "RNA::MIR-145"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-130A"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-29B"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-125B"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-29A"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::LET-7"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-199A"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-140"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-145"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-125B1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-29C"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-101"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-718"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-106A"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-155"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-494"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MIR-205"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::PIR-219"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::PIR-234"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::PIR-256"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::PIR-52207"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::PIR-33733"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::TRF-03357"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::TRF-5GLU"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::TS-101"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::TS-46"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::TRF-1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::TRF-3"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::TRF-5"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::TRF-2"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::50TIRNA"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::30TIRNA"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::I-TRFS"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::H19"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::HOTAIR"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::XIST"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::UCA1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::MALAT1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::PVT1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::GAS5"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::HOXD-AS1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::SPRY4-IT1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::PCAT-1"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::CIRCRNA"}, {"from": "ARTICLE::Role of different non-coding RNAs as ovarian Cancer biomarkers", "to": "RNA::SNORNA"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::H19"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::HOTAIR"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::MALAT1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::PVT1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::UCA1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::NEAT1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::ANRIL"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::CCAT1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::CCAT2"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::CRNDE"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::AB073614"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::TC0100223"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::TC0101686"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::TC0101441"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LOC645249"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LOC100128881"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LOC100292680"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LOC100190986"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::ASAP1-IT1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::FAM215A"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LINC00472"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::HOXA10-AS"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::HOXA11-AS"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::HOTTIP"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LUCAT1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LINC00961"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LINC00515"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LINC-TNFRSF19-1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::LINC-CARS2-2"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::XIST"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::TUG1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::OVAAL"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::NRCP"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::MEG3"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::HOST2"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::GAS5"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::RP11-284N8.3.1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::AC104699.1.1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::RUNX1-IT1"}, {"from": "ARTICLE::Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes", "to": "RNA::FAL1"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-203"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-205"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-214"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-30A-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-106A-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-93-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-122-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-185-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-99B-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-144-3P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-337-3P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-373"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-145"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-133B"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-125B"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-148A"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-200A-3P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-509-3-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-509-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-433"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-630"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-802"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-1271"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-193-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-19A-3P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-21-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-21-3P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-26A"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-26B"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-29A"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-19B-3P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-106B-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-146A"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-146B"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-150-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-191-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-206"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-34C-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-645"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-193A-5P"}, {"from": "ARTICLE::Role of microRNAs as Clinical Cancer Biomarkers for\r\n Ovarian Cancer: A Short Overview", "to": "RNA::MIR-125A-3P"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "RNA::EPCAM"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "RNA::HER2"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "RNA::MUC1"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "RNA::WT1"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "RNA::P16"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "RNA::PAX8"}, {"from": "ARTICLE::Analysis of Circulating Tumor Cells in \r\nOvarian Cancer and Their Clinical Value as a \r\nBiomarker", "to": "RNA::ACTIN"}, {"from": "ARTICLE::SLC11A2: a promising biomarker and therapeutic target in ovarian cancer", "to": "RNA::SLC11A2 MRNA"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "RNA::SPON1 MRNA"}, {"from": "ARTICLE::SPON1 is an independent prognostic \r\nbiomarker for ovarian cancer", "to": "RNA::SPON1 TRANSCRIPTS"}, {"from": "ARTICLE::SUGT1 is a prognostic biomarker and is associated with immune infiltrates in ovarian cancer", "to": "RNA::SUGT1 MRNA"}, {"from": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "to": "RNA::MICRORNA-204"}, {"from": "ARTICLE::Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer", "to": "RNA::RNU6-2"}, {"from": "ARTICLE::Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell", "to": "RNA::SIRNA"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "RNA::CFL1 MRNA"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "RNA::CYPA MRNA"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "RNA::PFN1 MRNA"}, {"from": "ARTICLE::Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer", "to": "RNA::EZR MRNA"}, {"from": "ARTICLE::Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer", "to": "RNA::MICRORNA-204"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "RNA::MIR-29B"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "RNA::MIR-199A"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "RNA::MIR-199A2"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "RNA::214"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "RNA::MIR-200 FAMILY"}, {"from": "ARTICLE::Analysis of Differentially Expressed MicroRNAs and Circulating Tumor Cells as Predictive Biomarkers of Platinum Chemoresistance in Primary Ovarian Carcinomas: A Prospective Study", "to": "RNA::LET-7 FAMILY"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "RNA::LET-7"}, {"from": "ARTICLE::The Role of Biomarkers in the Management of Epithelial Ovarian Cancer", "to": "RNA::MIR-200"}, {"from": "ARTICLE::The Role of CA\u2010125 in the Management of Ovarian Cancer: A Systematic Review", "to": "RNA::MIRNAS"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "RNA::MIR-222-3P"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "RNA::MIR-940"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "RNA::MIR-21-3P"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "RNA::MIR-125B-5P"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "RNA::MIR-181D-5P"}, {"from": "ARTICLE::The Role of Tumor-Associated Macrophages in the\r\n Progression and Chemoresistance of Ovarian Cancer", "to": "RNA::MIR-223"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-205-5P"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-145-5P"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-10A-5P"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-346"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-328-3P"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-508-3P"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-1294"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-494"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-26A"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-16"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::CEL-MIR-39"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::RNU6B (U6)"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::UNISP6"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-100"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-99"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-57"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-51"}, {"from": "ARTICLE::The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer", "to": "RNA::MIR-10"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "RNA::MIR-21"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "RNA::MIR-21-3P"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "RNA::MIR-210"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "RNA::LET-7 FAMILY"}, {"from": "ARTICLE::The biological significance and clinical applications of exosomes in ovarian cancer", "to": "RNA::MIR-433"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "RNA::CXCL9 MRNA"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "RNA::CXCL11 MRNA"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "RNA::CXCL13 MRNA"}, {"from": "ARTICLE::The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer", "to": "RNA::STAT1 MRNA"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "RNA::LGALS8 MRNA ISOFORMS"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "RNA::MIR-424-3P"}, {"from": "ARTICLE::The role of galectins\u20111, 3, 7, 8 and 9 as potential diagnostic and \r\ntherapeutic markers in ovarian cancer (Review)", "to": "RNA::SIRNA"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "RNA::MRNA"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "RNA::MICRORNAS"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "RNA::HSA-MIR-1273G-3P"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::The role of urine and serum biomarkers in the early detection of ovarian epithelial tumours", "to": "RNA::MIR-429"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::MSN MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::KRT19 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::COL5A2 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::COL1A2 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::BMP5 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::F10 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::KRT7 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::JUNB MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::BMP4 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::MMP1 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::KLK4 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::KLK5 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::KLK6 MRNA"}, {"from": "ARTICLE::Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer", "to": "RNA::KLK7 MRNA"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "RNA::ZNF76 MRNA"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "RNA::TRNASEC"}, {"from": "ARTICLE::ZNF76 predicts prognosis and response to platinum\r\n chemotherapy in human ovarian cancer", "to": "RNA::PRE-MRNA"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-429"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-100"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-320"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-126"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-93"}, {"from": "ARTICLE::Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4", "to": "RNA::MIR-223"}, {"from": "ARTICLE::Assessment of Circulating Tumor Cells as a \r\nPredictive Biomarker of Histology in Women With \r\nSuspected Ovarian Cancer", "to": "RNA::MICRORNAS"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "RNA::GALECTIN-1 MRNA"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "RNA::GALECTIN-3 MRNA"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "RNA::GALECTIN-4 MRNA"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "RNA::GALECTIN-8 MRNA"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "RNA::GALECTIN-9 MRNA"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "RNA::GAPDH MRNA"}, {"from": "ARTICLE::Assessment of galectins -1, -3, -4, -8, and -9 expression in ovarian carcinoma patients with clinical implications", "to": "RNA::TOTAL RNA"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "RNA::ACAT1 MRNA"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "RNA::KI67 MRNA"}, {"from": "ARTICLE::Assessment of the diagnostic and prognostic relevance of ACAT1 and CE levels in plasma, peritoneal fluid and tumor tissue of epithelial ovarian cancer patients - a pilot study", "to": "RNA::18S RRNA"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "RNA::BAIAP2L1 MRNA"}, {"from": "ARTICLE::BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer", "to": "RNA::FGFR3-BAIAP2L1 TRANSCRIPTS"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MRNA"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::NCRNA"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::LET-7A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::LET-7B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::LET-7C"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::LET-7D"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::LET-7E"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::LET-7F"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-10A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-10B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-16"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-20A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-23A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-23B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-26A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-26B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-27A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-29A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-29C"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-92"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-93"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-99A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-103"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-106B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-122"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-125A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-125B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-125B1"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-126"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-127"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-130A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-134"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-140"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-143"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-145"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-146B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-155"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-182"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-199A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-214"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-221"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-222"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-296"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-302D"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-320"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-335"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-346"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-410"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-422A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-424"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-432"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-494"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-508"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-519A"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-648"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-662"}, {"from": "ARTICLE::Microvesicles as Potential Ovarian Cancer Biomarkers", "to": "RNA::MIR-663"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-155"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-29"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-203"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-205"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-23"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-200"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-31"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-217"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-484"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-617"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-29C"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-101"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-128"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma", "to": "RNA::MIR-29A"}, {"from": "ARTICLE::Biomarkers and Strategies for Early Detection of Ovarian Cancer", "to": "RNA::MICRO-RNAS"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-29A"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-92"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-93"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-126"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-127"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-155"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-99B"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-125B1"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::LET-7"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-15"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-16"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-182"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-148B"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-449A"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-449B"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-34B"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-34C"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-140-3P"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-145"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-139-5P"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-133A"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-22"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-183"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-31"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-100"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-199A"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MIR-17-92"}, {"from": "ARTICLE::Biomarkers for Screening, Diagnosis, and Monitoring of\r\n Ovarian Cancer", "to": "RNA::MRNA"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "RNA::CD24 MRNA"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "RNA::SNAIL MRNA"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "RNA::E-CADHERIN MRNA"}, {"from": "ARTICLE::CD24 expression is a marker for predicting clinical outcome \r\nand regulates the epithelial-mesenchymal transition in \r\novarian cancer via both the Akt and ERK pathways", "to": "RNA::\u0392-ACTIN MRNA"}, {"from": "ARTICLE::CX3CR1 is a potential biomarker of immune \r\nmicroenvironment and prognosis in epithelial \r\novarian cancer", "to": "RNA::CX3CR1 MRNA"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-21"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-103"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-141"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-203"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-205"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-214"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-373"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-222-3P"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-7"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-21-3P"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-23B"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-29A"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-99A"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-125B"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-320A"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-484"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-30A-5P"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::MIR-6126"}, {"from": "ARTICLE::A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies", "to": "RNA::LET-7"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "RNA::CXCR4 MRNA"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "RNA::NM_003467"}, {"from": "ARTICLE::CXCR4 knockdown enhances sensitivity of paclitaxel via the \r\nPI3K/Akt/mTOR pathway in ovarian carcinoma", "to": "RNA::CXCR4 SHRNA"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "RNA::RNA SIGNATURE"}, {"from": "ARTICLE::Biomarkers in ovarian cancer: To be or not to be", "to": "RNA::MICRORNAS"}, {"from": "ARTICLE::Cervicovaginal specimen biomarkers for early detection of ovarian and endometrial cancer: A review", "to": "RNA::MIR124-2"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MRNA"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::LNCRNA"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::TRNA"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIRNA"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-200C-3P"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-7"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-16"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-93"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-182"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-376A"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-429"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-221"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-92"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-373"}, {"from": "ARTICLE::Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis", "to": "RNA::MIR-126"}, {"from": "ARTICLE::Circulating tumor DNA: a noninvasive biomarker for tracking ovarian cancer", "to": "RNA::MICRORNA-30A-5P"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "RNA::LINC01010"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "RNA::LBX2-AS1"}, {"from": "ARTICLE::Comprehensive analysis of TLX2 in pan cancer as a prognostic and immunologic biomarker and validation in ovarian cancer", "to": "RNA::HSA-MIR-146A-5P"}, {"from": "ARTICLE::Desmoglein-2 as a prognostic and biomarker in ovarian cancer", "to": "RNA::DSG2 MRNA"}, {"from": "ARTICLE::Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer", "to": "RNA::MRNA"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "RNA::ALG5 MRNA"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "RNA::GPR107 MRNA"}, {"from": "ARTICLE::Discovery of a biomarker candidate for surgical stratification in high-grade serous ovarian cancer", "to": "RNA::NUP188 MRNA"}, {"from": "ARTICLE::Epithelial ovarian cancer and the use of circulating tumor DNA: A systematic review", "to": "RNA::TSRNA"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::LET-7A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::LET-7D"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MRNA"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::TRNA"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-10A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-15A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-15B"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-19B"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-20A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-100"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-125B"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-155"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-222"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-26B"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-182"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-103"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-26A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-127"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-134"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-154"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-154*"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-410"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-377"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-432"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-368"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-299"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-30A-5P"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-30A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-30C1"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-30C-1"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-145"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-221"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-132"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-30B"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-192"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-194"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-335"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-32"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-99A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-18A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-16"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-7"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-429"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-25"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-93"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-142-3P"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-30D"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-106B"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-30E"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-214"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-203"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-205"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-210"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-125A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-140"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-1274A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-625-3P"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-720"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-126"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-17"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-150"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-92A"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-99B"}, {"from": "ARTICLE::Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case\u2013control study", "to": "RNA::MIR-29A"}, {"from": "ARTICLE::Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes", "to": "RNA::NON-CODING RNAS"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::MIR-1290"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::MIR-139-5P"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::MIR-129B-1-3P"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::MIR-3131"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::CEL-MIR-39"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::RNU-6B"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::RNU-48"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::MIR-16"}, {"from": "ARTICLE::Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types", "to": "RNA::MRNA"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-21-5P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-891-5P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-98-5P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-223"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-214-3P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-214"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-1307"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-21-3P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-433"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-30A-5P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-100"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-143"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-141-3P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-484"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-1270"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-205"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-6780B-5P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-212-3P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MIR-150-3P"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::LHX6 MRNA"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MMP1 MRNA"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::MALAT1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::UCA1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::CIRCPUM1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::CIRCWHSC1"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::CIRCCDR1AS"}, {"from": "ARTICLE::Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion", "to": "RNA::CIRCFOXP1"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "RNA::HELQ MRNA"}, {"from": "ARTICLE::Helicase POLQ-like (HELQ) as a novel indicator of platinum-based chemoresistance for epithelial ovarian cancer", "to": "RNA::SI-HELQ"}, {"from": "ARTICLE::High BMP7 expression is associated with poor prognosis in ovarian cancer", "to": "RNA::BMP7 MRNA"}, {"from": "ARTICLE::Higher expression of calcineurin predicts poor prognosis in unique subtype of ovarian cancer", "to": "RNA::MRNA"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "RNA::PKP1 MRNA"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "RNA::PKP2 MRNA"}, {"from": "ARTICLE::Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments", "to": "RNA::PKP3 MRNA"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::LET-7E"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-30C"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-125B"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-130A"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-335"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-27A"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-214"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-199A"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-200"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-100"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-31"}, {"from": "ARTICLE::Optimizing Molecular\u2010Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways", "to": "RNA::MIR-125A"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "RNA::EIF2B5 MRNA"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "RNA::FAM64A MRNA"}, {"from": "ARTICLE::Low EIF2B5 expression predicts poor prognosis in\r\n ovarian cancer", "to": "RNA::MIR-454-3P"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-21"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-141"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-429"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-214"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-100"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-34A"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-34B"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-34C"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-376C"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-30C"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-30D"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-30E-3P"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-370"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-145"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-92"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-93"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-221"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-222"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::LET-7"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::LET-7A"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::LET-7B"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::LET-7C"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::LET-7D"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::LET-7F"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::LET-7A-3"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-9"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-223"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-22"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-181D"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-532-5P"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-484"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-642"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-217"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-125B"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-199"}, {"from": "ARTICLE::MicroRNA: a new and promising potential biomarker for \r\ndiagnosis and prognosis of ovarian cancer", "to": "RNA::MIR-140"}, {"from": "ARTICLE::ADAM12 is a prognostic factor associated with an \r\naggressive molecular subtype of high-grade serous \r\novarian carcinoma", "to": "RNA::ADAM12 MRNA"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-93"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-141"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-492"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-429"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-155"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-205"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-182"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-182-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-182-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-183-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-1271-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-15B-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-141-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-135B-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-130B-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-214"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-574-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-99A-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-31"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-21"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-21-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-210-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-210"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-125B-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-34A-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-34B-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-34C-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-34C-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-29A-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-29C-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-23B"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-199A-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-203"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-223"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-221-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-142-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-199A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-99A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-10A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-10B-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-9"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-338"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-424"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-512-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-345"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-143"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-26A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-148A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-196A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-151"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-142-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-200C-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-200B-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-200A-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-328-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-766-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-130B-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-26A-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-30C"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::LET-7A"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::LET-7C"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::LET-7I"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::LET-7D"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::LET-7B"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-1307"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-375"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-3147"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-223-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-193A-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-342-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-106B-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-365A-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-22-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-144-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-151A-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-519B-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-125B-1-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-19B-1-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-26B-3P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MIR-1254-1"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::RNO-MIR-29C-5P"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::RNO-MIR-10B"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::RNO-MIR-31"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::RNO-MIR-140"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::MMU-MIR-140"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::RNU44"}, {"from": "ARTICLE::MicroRNAs as Potential Biomarkers in Gynecological Cancers", "to": "RNA::HSA-MIR-1274-1"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "RNA::CHI3L1 MRNA"}, {"from": "ARTICLE::Overexpression of CHI3L1 is associated with chemoresistance \r\nand poor outcome of epithelial ovarian carcinoma", "to": "RNA::G6PDH MRNA"}, {"from": "ARTICLE::Overexpression of HE4 (human epididymis protein 4) enhances \r\nproliferation, invasion and metastasis of ovarian cancer", "to": "RNA::HE4 MRNA"}, {"from": "ARTICLE::Overexpression of ICAM-1 Predicts Poor Survival in\r\n High-Grade Serous Ovarian Carcinoma: A Study Based on\r\n TCGAandGEODatabases and Tissue Microarray", "to": "RNA::ICAM1 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD1 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD2 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD3 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD4 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD5 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD6 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD7 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD8 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD9 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD10 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD11 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD12 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD13 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::PSMD14 MRNA"}, {"from": "ARTICLE::PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation", "to": "RNA::MICRORNA"}, {"from": "ARTICLE::Pathogenicity of PKC Genetic Variants\u2014Possible Function as a Non-Invasive Diagnostic Biomarker in Ovarian Cancer", "to": "RNA::PRKCG MRNA"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "RNA::PRDX-3 MRNA"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "RNA::PRDX-5 MRNA"}, {"from": "ARTICLE::Peroxiredoxin-1 as a prognostic factor  in \r\npatients with ovarian cancer", "to": "RNA::PRDX-6 MRNA"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-21"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-34A"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-200B"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-205"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-200B-3P"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::HSA-MIR-21-5P"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::HSA-MIR-34A-5P"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::HSA-MIR-200B-3P"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::HSA-MIR-205-5P"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-141"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-200A"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-200C"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-429"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MIR-191"}, {"from": "ARTICLE::Plasma miR-200b in ovarian carcinoma patients: distinct \r\npattern of pre/post-treatment variation compared to CA-125 \r\nand potential for prediction of progression-free survival", "to": "RNA::MS2 PHAGE GENOMIC RNA"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "RNA::MIR-223"}, {"from": "ARTICLE::Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin", "to": "RNA::MIR-21-3P"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "RNA::TGF-\u03921 MRNA"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "RNA::TGF-\u03922 MRNA"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "RNA::TGF-\u03923 MRNA"}, {"from": "ARTICLE::Prognostic Values of Transforming Growth Factor-Beta\r\n Subtypes in Ovarian Cancer", "to": "RNA::TGF-\u03924 MRNA"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::HOTAIR"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::CCAT2"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::NEAT1"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::UCA1"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::ANRIL"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::ASAP1-IT1"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::FAM215A"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::LINC00472"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::TC0101441"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::RP11-284N8.3.1"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::AC104699.1.1"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::AB073614"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::C17ORF91"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::HULC"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::LNCRNA-ATB"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::HOST2"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::MALAT1"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::LET-7B"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::MIR-30D"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::MIR-200"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::MIR-9"}, {"from": "ARTICLE::Prognostic value of abnormally expressed lncRNAs in ovarian \r\ncarcinoma: a systematic review and meta-analysis", "to": "RNA::MIR-223"}, {"from": "ARTICLE::Proteomic analysis of exosomes secreted \r\nduring the epithelial-mesenchymal transition \r\nand potential biomarkers of mesenchymal \r\nhigh-grade serous ovarian carcinoma", "to": "RNA::MRNA"}, {"from": "ARTICLE::Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells", "to": "RNA::MIRNA"}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {"interaction": {"hover": false, "tooltipDelay": 999999}};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>